Article Information
History
- September 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Xikang Fan1,*,
- Jing Yang1,*,
- Jiayu Wang1,
- Cheng Yin2,
- Meng Zhu1,
- Hongxia Ma1,3,4,
- Guangfu Jin1,3,4,
- Zhibin Hu1,3,4,
- Hongbing Shen1,4 and
- Dong Hang1,4,†
- 1Department of Epidemiology and Biostatistics, International Joint Research Center on Environment and Human Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China, 211166
- 2Department of Laboratory, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, China, 211100
- 3State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing, China, 211166
- 4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Medicine, Nanjing Medical University, Nanjing, China, 211166
- ↵†
Correspondence:
Dong Hang, PhD, Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, China. Email: hangdong{at}njmu.edu.cn
↵* Co-first authors, contributed equally.
Posted September 11, 2020.
No association between circulating levels of testosterone and sex hormone-binding globulin and risk of COVID-19 mortality in UK biobank
